サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：末梢静脈カテーテルの世界市場-2023年～2030年
市場調査レポート
商品コード
1345418

末梢静脈カテーテルの世界市場-2023年～2030年

Global Peripheral IV Catheters Market - 2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
末梢静脈カテーテルの世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

末梢静脈カテーテルの世界市場は、2022年に52億米ドルに達し、2023～2030年の予測期間中にCAGR 7.4%で成長し、2030年には91億米ドルに達すると予測されています。

末梢静脈カテーテル（PIVC）は、最も一般的に使用される静脈デバイスであり、主に薬剤、輸液、血液製剤の投与などの治療目的に使用されます。末梢静脈カテーテルの評価では、カテーテルの位置、開存性/閉鎖性、四肢の対称性、静脈炎の兆候（紅斑、不快感、腫脹、疼痛など）、圧迫傷害、浸潤/浸出傷害の兆候などがすべて評価されます。

さらに、世界の末梢静脈カテーテル市場は、慢性疾患の有病率の上昇、技術の進歩、低侵襲手技の増加、および予測期間中の市場を牽引する旺盛な医療費によって牽引されます。

ダイナミクス

心血管疾患の有病率の上昇

心房細動や深部静脈血栓症などの特定の心血管疾患を有する患者は、血栓を避けるために抗凝固療法が必要になる場合があります。静脈内（IV）カテーテルは、健康な血流を維持するためにヘパリンなどの抗凝固薬を供給することができます。心血管疾患の発生率の上昇は、予測期間中に市場を促進する重要な要因です。

例えば、米国疾病予防管理センター（Centres for Disease Control and Prevention）の更新ファクトシート2023によると、米国では男性、女性、ほとんどの人種・民族の主な死因は心臓病です。米国では、33秒に1人が心血管疾患で死亡しています。

米国では2021年に約695,000人が心臓病で死亡し、死亡者の5人に1人を占めています。2018年から2019年にかけて、米国は心臓病に約2,399億米ドルを費やしました。これは、ヘルスケアサービス、薬剤、死亡による生産性低下の費用をカバーしています。

技術進歩

技術進歩は、予測期間中に市場を牽引する重要な要因の1つです。例えば、2023年4月、世界の医療技術企業であるBDは、最適な静脈内留置のための専用プローブを備えた先進的な超音波装置であるBDプレビューIIシステムを発売しました。

このシステムは、リアルタイムの針深度マーカーを通じて静脈アクセスに対するアンメットニーズに対応し、針の軌跡の高品質超音波画像を提供するBDキューニードルトラッキングシステムを備えています。BDキューニードルトラッキング対応カテーテルと互換性があります。BDプレヴューIIシステムは、臨床医に最適な静脈内留置を提供し、使いやすいように設計されています。

高齢者人口の増加

高齢化が進むにつれ、点滴治療などの医療処置がより多く必要になります。薬剤や輸液を供給するための末梢静脈カテーテルの必要性は、人口の高齢化に伴って高まります。

高齢者は心臓疾患にかかりやすいです。加齢に関連した心臓疾患の有病率の増加は、世界の高齢者人口の増加に伴いペースメーカーの需要を増加させると予測されています。

例えば、Clinical Cardiology誌に掲載された論文によると、米国では60歳以上の人口の約60％が高血圧症であり、心臓発作につながるため、末梢静脈カテーテルの需要が増加します。2060年までに65歳以上の人口は米国人口の25％に達し、10年後には200億人に達します。

針刺し傷害の増加が末梢静脈カテーテルの採用を促す

注射を頻繁に必要とする患者にとって、注射針による針刺し損傷は大きな問題です。注射針や注射器の取り扱い、分解、あるいは廃棄は、針先による経皮的創傷の原因となります。アメリカ医師会によると、針刺し事故はヘルスケア職ではよくあることです。米国では年間60～80万件の針刺し事故が発生すると推定されています。

例えば、2022年7月、輸液療法のリーダーであるB. Braun Medical Inc.は、ワンタイムブラッドコントロール機能を備えた新しいIntrocan Safety 2 IV Catheterの発売を発表しました。Introcan Safety 2 IV Catheterは、針刺し損傷や血液曝露のリスクを低減することで、臨床医にとってより安全なIVアクセスを可能にするB.Braunの最新開発製品です。

カテーテルに関連するリスクと合併症

適切な無菌的処置と器具の評価により回避可能ですが、PIVC in situの合併症が生じる可能性があります。感染、静脈炎、カテーテル／輸液／薬剤の滞留、および慢性的な体調不良患者に対する困難は、すべて一般的な結果です。体液や薬剤が周囲の組織に移行すると、浸潤／滲出が起こる。このような場合は、滲出性外傷の管理看護ガイドラインを参照のこと。このような問題は、適切な無菌的手技を用い、評価することで回避できます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 心血管疾患の有病率の上昇
      • 技術進歩
      • 高齢者人口の増加
      • 針刺し損傷の増加による末梢静脈カテーテルの採用促進
    • 抑制要因
      • カテーテルの関連リスクと合併症
    • 機会
      • 低侵襲手技の増加
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • 一体型／閉鎖型末梢静脈カテーテル
  • ショート末梢静脈カテーテル
  • ミッドラインカテーテル

第8章 技術別

  • 従来型PIVC
  • システムPIVC

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • クリニック

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Becton Dickinson
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • B. Braun Melsungen AG
  • Argon Medical
  • Vygon
  • ICU Medical, Inc
  • VOGT Medical
  • RenovoRx Inc
  • Nipro Medical
  • Teleflex
  • Griener Bio One

第13章 付録

目次
Product Code: MD6775

Overview

Global Peripheral IV Catheters Market reached US$ 5.2 billion in 2022 and is expected to reach US$ 9.1 billion by 2030, growing with a CAGR of 7.4% during the forecast period 2023-2030.

Peripheral intravenous catheters (PIVCs) are the most commonly used intravenous devices which are primarily used for therapeutic purposes such as the administration of medications, fluids, and blood products. The catheter location, patency/occlusion, limb symmetry, any evidence of phlebitis (erythema, discomfort, swelling, pain, etc.), pressure injuries, and signs of infiltration/extravasation injuries are all evaluated in the assessment of peripheral IV Catheters.

Furthermore, the global peripheral IV catheter market is driven by a rise in the prevalence of chronic disorders, technological advancements, a rise in minimally invasive procedures, and strong healthcare expenditures that will drive the market during the forecast period.

Dynamics

Rise in the Prevalence of Cardiovascular Diseases

Patients with certain cardiovascular conditions, such as atrial fibrillation or deep vein thrombosis, may require anticoagulation treatment to avoid blood clots. Intravenous (IV) catheters can supply anticoagulant drugs like heparin to maintain healthy blood flow. The rise in the incidence of cardiovascular diseases is the significant key driver that drives the market during the forecast period.

For instance, according to the Centres for Disease Control and Prevention's updated factsheet 2023, heart disease is the main cause of death in the United States for men, women, and individuals of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 33 seconds.

Approximately 695,000 persons in the United States died from heart disease in 2021, accounting for one out of every five fatalities. From 2018 to 2019, the United States spent around $239.9 billion on heart disease. This covers the expense of healthcare services, medications, and lost productivity as a result of mortality.

Rise in the Technological Advancements

Rise in the technological advancements is one of the key factors that drive the market during the forecast period. For instance, in April 2023, BD, a global medical technology company, launched the BD Prevue II System, an advanced ultrasound device with a specialized probe for optimal IV placement.

The system addresses the unmet need for IV access through real-time needle depth markers and features the BD Cue Needle Tracking System, providing high-quality ultrasound images of the needle trajectory. It is compatible with BD Cue Needle Tracking-enabled catheters. The BD Prevue II System is designed to provide clinicians with optimal IV placement and is easy to use.

Rise in the Geriatric Population

As the population ages, more medical procedures, such as intravenous therapy, are required. The need for peripheral IV catheters to provide medicine and fluids develops in tandem with the ageing population.

The elderly are more vulnerable to heart problems. The increased prevalence of age-related cardiac problems is predicted to increase demand for pacemakers as the global geriatric population grows.

For instance according to an article published by Clinical Cardiology Around 60% of the US population over the age of 60 have hypertension, leading to heart attacks which result in increased demand for peripheral iv catheters requirement. By 2060, the number of people aged 65 and over will reach 25% of the US population, with 20 Billion beyond the eighth decade.

Rising Needle-Stick Injuries Encouraging The Adoption of Peripheral Intravenous Catheters

For patients who require frequent injections, needle stick injuries from injection needles are a major problem. Handling, disassembling, or even disposal of needles and syringes can result in percutaneous wound injuries from needle tips. According to the America Medical Association Needle sticks are a common occurrence in the healthcare profession. It is estimated that 600 000 to 800 000 needlestick injuries occur per year in the United States.

For instance, In July 2022, B. Braun Medical Inc, a leader in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and exposure to blood

Risks and Complications Associated with the Catheters

Complications of PIVC in situ can arise, although they can be avoided with adequate aseptic procedures and device evaluation. Infection, phlebitis, catheter/fluid/medication presence, and difficulties with chronically unwell patients are all common consequences. When fluids or drugs are transported into surrounding tissue, infiltration/extravasation occurs; if this occurs, see the extravasation injury management nursing guideline. These issues can be avoided by employing proper aseptic techniques and evaluation.

Segment Analysis

The Global Peripheral IV Catheters market is segmented based on product, technology, end user and region.

The Integrated Peripheral Intravenous Catheters From The Product Segment Accounted for Approximately 42.5% of the Peripheral IV Catheters Share

The integrated peripheral intravenous catheters from the product segment with around 42.5% is expected to dominate during the forecast period. People adjusting the catheter to attach the extension set cause internal pressures in the vein to be reduced with integrated peripheral intravenous catheters. Following insertion, the use of integrated catheters offers additional fluid tubing connections or direct injections conducted via the dedicated port, which is somewhat upstream of the catheter itself and limits the movement of the catheter body against the internal vein wall.

For instance, according to research published in the British Journal of Nursing in August 2022, a close/integrated catheter reduces the danger of the healthcare professional coming into touch with the patient's blood and enables the safe collection of blood samples. It can assist prevent backflow into the cannula tip, minimising the risk of obstruction and the need for several insertions. It is also critical that the device stays stable after insertion to minimise micro-movements within the vessel (which might damage the tunica intima, resulting in mechanical phlebitis.

Geographical Penetration

North America Accounted for Approximately 39.6% of the Market Share

North America is estimated to hold about 39.6% of the total market share throughout the forecast period due to launches by the key players, rising chronic diseases and a growing senior population. Also, North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large market share of the region

For instance, in March 2022, Shockwave Medical, Inc, a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5 + peripheral IVL catheter after receiving both CE Mark and U.S. Food and Drug Administration (FDA) clearance. The Shockwave M5 + catheter, which has been in limited launch until today, is specifically designed to decrease IVL treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes.

Competitive Landscape

The major global players in the market include: Becton Dickinson, B. Braun Melsungen AG, Argon Medical, Vygon, ICU Medical Inc, VOGT Medical, RenovoRx Inc, Nipro Medical, Teleflex, Greiner Bio-One and among others.

COVID-19 Impact Analysis

Covid has a huge influence on the peripheral intravenous catheter market, which is facing substantial challenges The main issue is the difficulty to access raw materials required for the fabrication of peripheral intravenous catheters due to transportation facility issues. Furthermore, due to an increase in the number of patients suffering from COVID-19 and other life-threatening illnesses, product distributors are seeing unpredictable demand from retailers.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict had a moderate impact on the global peripheral IV catheters market, owing to the disruption of supply chains and the shortage of healthcare infrastructure where the impact directly hit on these factors. Overall, the impact of the import and export of devices is expected to have an influence on the overall global peripheral IV catheters market growth over the forecast period.

By Product

  • Integrated/Closed Peripheral Intravenous Catheters
  • Short Peripheral Intravenous Catheters
    • Ported PIVC
    • Non-Ported PIVC
  • Midline Catheters

By Technology

  • Conventional PIVC
  • Systems PIVC

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In September 2022 B. B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced it has acquired the innovative Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. B. Braun's acquisition builds on the company's history of product and program innovation to improve the patient experience and outcomes with peripheral intravenous (IV) therapy.
  • In May 2022, Access Vascular, Inc. (AVI) announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC Dual-Lumen catheter. Designed and constructed using the same proprietary hydrophilic biomaterial as AVI's single-lumen HydroPICC and HydroMID catheters, these devices showed a significant reduction in complications such as occlusions, replacements, Deep Vein Thrombosis and phlebitis in recent studies.

Why Purchase the Report?

  • To visualize the global Peripheral IV Catheters market segmentation based on product, technology, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Peripheral IV Catheters market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global Peripheral IV Catheters market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Cardiovascular Diseases
      • 4.1.1.2. Rise in the Technological Advancements
      • 4.1.1.3. Rise in the Geriatric Population
      • 4.1.1.4. Rising Needle-Stick Injuries Encouraging the Adoption of Peripheral Intravenous Catheters
    • 4.1.2. Restraints
      • 4.1.2.1. Risks and Complications Associated with the Catheters
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in the Minimal Invasive Procedures
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Integrated/Closed Peripheral Intravenous Catheters *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Short Peripheral Intravenous Catheters
  • 7.4. Midline Catheters

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Conventional PIVC*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Systems PIVC

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. UK
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Becton Dickinson*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. B. Braun Melsungen AG
  • 12.3. Argon Medical
  • 12.4. Vygon
  • 12.5. ICU Medical, Inc
  • 12.6. VOGT Medical
  • 12.7. RenovoRx Inc
  • 12.8. Nipro Medical
  • 12.9. Teleflex
  • 12.10. Griener Bio One

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us